Abbott Healthcare Pvt. Ltd. has announced the discontinuation of the manufacturing, importing, and marketing of its scheduled formulation, Graftmaster Coronary Stent, in accordance with Paragraph 21(2) of the Drugs Price Control Order, 2013. The product will be discontinued after six months from the date of the notice (07 June 2026). Following discontinuation, the product may no longer be available in the market. Patients currently using the product are advised to consult their doctors. Medical practitioners and healthcare professionals are also requested to take note of this announcement. Issued by: Durgesh Paliwal Company Secretary Abbott Healthcare Pvt. Ltd. Mumbai Date: 07 June 2026